Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: Using evidence in the context of clinical practice

International Journal of Artificial Organs

Volumn 29, Issue 1, 2006, Pages 41-49

  Bonifati, Carmen ^a   Pansini, Francesca ^a   Torres, D D ^a   Navaneethan, S D ^b   Craig, J C ^c,d   Strippoli, G F M ^c,d  

^a UNIVERSITY OF BARI   (Italy)

^b UNITY HEALTH SYSTEM   (United States)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Peritoneal dialysis; Peritonitis; Prevention

Indexed keywords

ANTIBIOTICS; ANTIMICROBIAL AGENTS; BACTERIA; DIALYSIS; PATIENT TREATMENT;

CATHETER PLACEMENT; CLINICAL PRACTICES; IN CONTEXTS; INFECTION RATES; PERITONEAL DIALYSIS; PERITONITIS; PREVENTION; RANDOMIZED TRIAL; SET SYSTEM; SYSTEMATIC REVIEW;

CATHETERS;

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CEFALEXIN; CEFAZOLIN; CEPHALOSPORIN; COTRIMOXAZOLE; DISINFECTANT AGENT; GENTAMICIN; NYSTATIN; OFLOXACIN; POVIDONE IODINE; PSEUDOMONIC ACID; RIFAMPICIN; STAPHYLOCOCCUS VACCINE; STAPHYPAN BERNA; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CARRIER; CATHETER INFECTION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DEVICE REMOVAL; EVIDENCE BASED PRACTICE; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INFECTION RISK; INTERMETHOD COMPARISON; META ANALYSIS; PERIOPERATIVE PERIOD; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONITIS; PRACTICE GUIDELINE; RISK REDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SYSTEMATIC REVIEW;

EID: 33644881934     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880602900103     Document Type: Article

References (80)

1. Heaf J. Underutilization of peritoneal dialysis. JAMA 2004; 291: 740-2.
2. Mendelssohn DC, Mullaney SR, Jung B, Blake PG, Metha RL. What do American nephrologists think about dialysis modality selection? Am J Kidney Dis 2001; 37: 22-9.
3. Churchill DN, Thorpe KE, Vonesh EF, Keshaviah PR. Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Study Group. J Am Soc Nephrol 1997; 8: 965-71.
4. Digenis GE, Abraham G, Savin E, et al. Pertonitis-related deaths in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 1990; 10: 45-7.
5. Annigeri R, Conly J, Vas S, et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001; 21: 554-9.
6. Zelenitsky S, Barnas L, Findlay I, et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 2000; 36:1009-13.
7. Salusky IB, Holloway M. Selection of peritoneal dialysis for pediatric patients. Perit Dial Int 1994; 17 (suppl 3): S35-7.
8. Oxton LL, Zimmermann SW, Roecker EB, Wakeen M. Risk factors for peritoneal dialysis-related infections. Perit Dial Int 1994; 14:137-44.
9. Schaefer F. Management of peritonitis in children receiving chronic peritoneal dialysis. Paediatr Drugs 2003; 5: 315-25.
10. Golper TA, Brier ME, Bunke M, Schreiber MJ, Bartlett DK, Hamilton RW, Strife F, Hamburger RJ. Risk factors for peritonitis in long-term peritoneal dialysis: The Network 9 peritonitis and catheter survival studies; Academic Subcommittee of the Steering Committee of the Network 9 peritonitis and catheter survival studies. Am J Kidney Dis 1996; 28: 428-36.
11. Holley JL, Bernardini J, Piraino B. A comparison of peritoneal dialysis-related infections in black and white patients. Perit Dial Int 1993; 13: 45-9.
12. Piraino B. ADEMEX: How should it change our practice? Adequacy of peritoneal dialysis in Mexico. Perit Dial Int 2002; 22: 552-4.
13. Thodis E, Passadakis P, Panagoutsos S, Bacharaki D, Euthimiadou A, Vargemezis V. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis. Adv Perit Dial 2000; 16: 257-61.
14. Piraino B. ADEMEX: How should it change our practice? Adequacy of peritoneal dialysis in Mexico. Perit Dial Int 2002; 22: 552-4.
15. Luzar MA, Brown CB, Balf D, et al. Exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): Results of a randomized multicenter trial. Perit Dial Int 1990; 10: 25-9.
16. Piraino B. Infectious complications of peritoneal dialysis. Perit Dial Int 1997; 17 (suppl 3): S15-8.
17. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27: 695-700.
18. Crowther CA, Henderson-Smart DJ. Phenobarbital prior to preterm birth for preventing neonatal periventricular haemorrhage. Cochrane Database Syst Rev 2003; (3): CD000164.
19. Churchill DN, Taylor DW, Vas SI, et al. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients: A randomized clinical trial of cotrimoxazole prophylaxis. Perit Dial Int 1988; 8: 125-8.
20. Blowey DL, Warady BA, McFarland Ks. The treatment of Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients. Adv Perit Dial 1994; 10: 297-9.
21. Low DE, Vas SI, Oreopoulos DG, et al. Prophylactic cephalexin ineffective in chronic ambulatory peritoneal dialysis. Lancet 1980; 2: 753-4.
22. Sesso R, Parisio K, Dalboni A, et al. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1994; 41: 370-6.
23. Swartz R, Messana J, Starmann B, Weber M, Reynolds J. Preventing Staphylococcus aureus infection during chronic peritoneal dialysis. J Am Soc Nephrol 1991; 2: 1085-91.
24. Zimmerman SW, Ahrens E, Johnson CA, et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 1991; 18: 225-31.
25. Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 1996; 7: 2403-8.
26. Wilson AP, Lewis C, O'Sullivan H, Shetty N, Neild GH, Mansell M. The use of povidone iodine in exit site care for patients undergoing continuous peritoneal dialysis. J Hosp Infect 1997; 35: 287-93.
27. Waite NM, Webster N, Laurel M, Johnson M, Fong IW. The efficacy of exit site povidone-iodine ointment in the prevention of early peritoneal dialysis-related infections. Am J Kidney Dis 1997; 29: 763-8.
28. Nolph KD, Prowant B, Serkes KD, et al. A randomized multicenter clinical trial to evaluate the affects of an ultraviolet germicidal system on peritonitis rate in continuous ambulatory peritoneal dialysis. Peritonal Dialysis Bulletin 1985; 1: 19-24.
29. Poole-Warren LA, Hallett MD, Hone PW, Burden SH, Farrell PC. Vaccination for prevention of CAPD associated staphylococcal infection: Results of a prospective multicentre clinical trial. Clin Nephrol 1991; 35:198-206.
30. Lo WK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28: 549-52.
31. Bennet-Jones DN, Martin J, Barratt AJ, Duffy TJ, Naish PF, Aber GM. Prophylactic gentamicin in the prevention of early exit-site infections and peritonitis in CAPD. Adv Perit Dial 1998; 4: 147-50.
32. Gadallah MF, Ramdeen G, Mignone J, Patel D, Mitchell L, Tatro S. Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters. Am J Kidney Dis 2000; 36:1014-9.
33. Lye WC, Lee EJ, Tan CC. Prophylactic antibiotics in the insertion of Tenckhoff catheters. Scand J Urol Nephrol 1992; 26:177-80.
34. Wikdahl AM, Engmann U, Stegmayr G, Sorensen JG. One-dose cefuroxime i.v. and i.p. reduces microbial growth in PD patients after catheter insertion. Nephrol Dial Transplant 1997; 12: 157-60.
35. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, et al. Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin. Adv Perit Dial 1992; 8: 242-5.
36. Gadallah MF, Pervez A, El-Shahawy MA, Sorrels D, Zibari G, McDonald J, Work J. Peritoneoscopic versus surgical placement of peritoneal dialysis catheters: A prospective randomized study on outcome. Am J Kidney Dis 1999; 33: 118-22.
37. Tsimoyiannis EC, Siakas P, Glantzounis G, Toli C, Sferopoulos G, Pappas M, Manataki A. Laparoscopic placement of the Tenckhoff catheter for peritoneal dialysis. Surg Laparosc Endosc Percutan Tech 2000; 10: 218-21.
38. Wright MJ, Bel'eed K, Johnson BF, Eadington DW, Sellars L, Farr MJ. Randomized prospective comparison of laparoscopic and open peritoneal dialysis catheter insertion. Perit Dial Int 1999; 29: 372-5.
39. Danielsson A, Blohme L, Tranaeus A, Hylander B. A prospective randomized study of the effect of a subcutaneously "buried" peritoneal dialysis catheter technique versus standard technique on the incidence of peritonitis and exitsite infection. Perit Dial Int 2002; 22: 211-9.
40. Moncrief JW, Popovich RP. Subcutaneous buried versus standard peritoneal dialysis catheter. Presentation at the XVIII Annual CAPD Conference, Nashville, TN, February 24, 1998.
41. Park MS, Yim AS, Chung SH, Lee EY, Cha MK, Kim JH, Song KI, Han DC, Hwang SD, Moon C, Lee HB. Effect on prolonged subcutaneous implantation of peritoneal catheter on peritonitis rate during CAPD: A prospective randomized study. Blood Purif 1998; 16: 171-8.
42. Ejlersen E, Steven K, Lokkegaard H. Paramedian versus midline incision for the insertion of permanent peritoneal dialysis catheters. A randomized clinical trial. Scand J Urol Nephrol 1990; 24:151-4.
43. Rubin J, Didlake R, Raju S, Hsu H. A prospective randomized evaluation of chronic peritoneal catheters. Insertion site and intraperitoneal segment. ASAIO Trans 1990; 36: M497-500.
44. Akyol AM, Porteous C, Brown MW. A comparison of two types of catheters for continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1990; 10: 63-6.
45. Dasgupta MK, Perri D, Fox S. Exit-site infection, but not peritonitis, is reduced by the use of Moncrieff-Popovich catheters in comparison to Tenckhoff catheters. Presented at the American Society of Nephrology Renal Week, Toronto, Canada, October 13, 2000.
46. Eklund BH, Honkanen EO, Kala AR, Kyllonen LE. Catheter configuration and outcome in patients on continuous ambulatory peritoneal dialysis: A prospective comparison of two catheters. Perit Dial Int 1994; 14: 70-4.
47. Eklund BH, Honkanen EO, Kala AR, Kyllonen LE. Peritoneal dialysis access: Prospective randomized comparison of the Swan neck and Tenckhoff catheters. Perit Dial Int 1995; 15: 353-6.
48. Lye WC, Kour NW, van der Straaten JC, Leong SO, Lee EJ. A prospective randomized comparison of the Swan neck, coiled, and straight Tenckhoff catheters in patients on CAPD. Perit Dial Int 1996; 16 (suppl): S333-5.
49. Nielsen PK, Hommingsen C, Friis SU, Ladefoged J, Olgaard K. Comparison of the straight and curled Tenckhoff peritoneal dialysis catheters implanted by percutaneous technique: A prospective randomized study. Perit Dial Int 1995; 15: 18-21.
50. Scott PD, Backran A, Pearson R, Riad H, Parrot N, Johnson RW, Gokal R. Peritoneal dialysis access. Prospective randomized trial of 3 different peritoneal catheters-Preliminary report. Perit Dial Int 1994; 14: 289-90.
51. Chong IK, Chan CY, Cheng SW, Poon JF, Ji YL, Lo WK, Chan DT. A randomized prospective study of the cost-effectiveness of the conventional spike, O-set, and UVXD techniques in continuous ambulatory peritoneal dialysis. Perit Dial Int 1994; 14: 255-60.
52. Canadian CAPD Clinical Trials Group. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): A multi-centre randomized trial comparing the Y connector disinfectant system to standard systems. Perit Dial Int 1989; 9:159-63.
53. Dryden MS, McCann M, Wing AJ, Philips I. Controlled trial of a Y-set dialysis delivery system to prevent peritonitis in patients receiving continuous ambulatory peritoneal dialysis. J Hosp Infect 1992; 20: 185-92.
54. Li PJ, Chang TH, So WY, Wang AY, Leung CB, Lai KN. Comparison of the Y-set disconnect system (Ultraset) versus conventional spike system in uremic patients on CAPD: Outcome and cost dialysys. Perit Dial Int 1996; 16 (suppl): S368-70.
55. Lindholm T, Simonsen O, Krutzen L. Evaluation of a new take-off system: A prospective randomized multi-centre study. Adv Perit Dial 1988; 4: 262-5.
56. Maiorca R, Cantaluppi A, Cancarini GC, Scalamogna A, Broccoli R, Graziani G, Brasa S, Ponticelli C. Prospective controlled study of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1983; 2: 642-4.
57. Owen JE, Walker RG, Lemon J, Brett L, Mitrou D, Becker GJ. Randomized study of peritonitis with conventional versus O-set technique in continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12: 216-20.
58. Rottembourg J, Brouard R, Issad B, Allouache M, Jacobs C. Prospective randomized study about Y connectors in CAPD patients. Adv Perit Dial 1987; 3: 107-13.
59. Viglino G, Colombo A, Scalamogna A, Cavalli PL, Guerra L, Renzetti G, Gandolfo G, De Vecchi A, Barzaghi V, Balteau P. Prospective randomized study of two Y devices in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1999; 9: 165-8.
60. Viglino G, Colombo A, Cantu P, Camerini C, Catizone L, Bonello F, Lombardo V, Balteau PR, Cavalli PL, Renzetti GA. In vitro and in vivo efficacy of a new connector device for continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13 (suppl): S148-51.
61. Harris DC, Yuill EJ, Byth K, Chapman JR, Hunt C. Twin-versus single-bag disconnect systems: Infection rates and cost of continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996; 7: 2392-8.
62. Kiernan L, Kliger A, Gorban-Brennan N, Juergensen P, Tesin D, Vonesh E, Finkelstein F. Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems. J Am Soc Nephrol 1995; 5: 1835-8.
63. Li PK, Szeto CC, Law MC, Chau KF, Fung KS, Leung CB, Li CS, Lui SL, Tong KL, Tsang WK, Wong KM, Lai KN. Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: A randomized prospective multicenter study. Am J Kidney Dis 1999; 33: 535-40.
64. Monteon F, Corera-Rotter R, Paniagua R, Amato D, Hurtado ME, Medina JL, Salcedo RM, Garcia E, Matos M, Kaji J, Vazquez R, Ramos A, Schettino MA, Moran J. Prevention of peritonitis with disconnect systems in CAPD: A randomized controlled trial. The Mexican Nephrology Collaborative Study Group. Kidney Int 1998; 54: 2123-8.
65. De Fijter CW, Oe PL, Nauta JJ, Van Der Meulen J, Ter Wee PM, Snoek FJ, Donker AJ. A prospective, randomized study comparing the peritonitis incidence of CAPD and Y-connector (CAPD-Y) with continuous cyclic peritoneal dialysis (CCPD). Adv Perit Dial 1991; 7: 186-9.
66. Bro S, Bjorner JB, Tofte-Jensen P, Klem S, Almtoft B, Danielson H, Meincke M, Friedberg M, Feldt-Rasmussen B. A prospective, randomized multicenter study comparing APD and CAPD treatment. Perit Dial Int 1999; 19: 526-33.
67. Eklund B, Honkanen E, Kyllonen L, Saimela K, Kala AR. Peritoneal dialysis access: Prospective randomized comparison of single-cuff straight Tenckhoff catheters. Nephrol Dial Transplant 1997; 12: 2664-6.
68. Li PK, Law MC, Chow KM, Chan WK, Szeto CC, Cheng YL, Wong TY, Leung CB, Wang AY, Lui SF, Yu AW. Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis: A prospective, randomized, controlled, multicenter study. Am J Kidney Dis 2002; 40: 373-80.
69. Pommer W, Brauner M, Westphale HJ, Brunkhorst R, Kramer R, Bundschu D, Hoffken B, Steinhauer HB, Schumann E, Luttgen FM, Schillinger-Pokorny E, Schaefer F, Wende R, Offner G, Nather S, Osten B, Zimmering M, Ehrich JH, Kehn M, Mansmann U, Grosse-Siestrup C. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: Silver ring prophylaxis at the catheter exit study. Am J Kidney Dis 1998; 32: 752-60.
70. Trooskin SZ, Harvey RA, Lennard TW, Greco RS. Failure of demonstrated clinical efficacy of antibiotic-bonded continuous ambulatory peritoneal dialysis (CAPD) catheters. Perit Dial Int 1990; 10: 57-9.
71. Turner K, Edgar D, Hair M, Uttley L, Sternland R, Hunt L, Gokal R. Does catheter immobilization reduce exit-site infections in CAPD patients? Adv Perit Dial 1992; 8: 265-8.
72. Diaz-Buxo JA. Modality selection. J Am Soc Nephrol 1998; 9 (suppl 12): S112-7.
73. Piraino B, Benardini J, Sorkin M. Catheter infections as a factor in the transfer of continuous ambulatory peritoneal dialysis patients to hemodialysis. Am J Kidney Dis 1989; 13: 365-9.
74. Johnson DW. Peritoneal dialysis. In: McDonald SP, Russ GR, eds. ANZDATA Registry Report 2003. Adelaide, Australia: Australian and New Zealand Dialysis and Transplant Registry; 2003. p 39-54.
75. Bannister K, Walker A, Lonergan M, George C, Chow J, Simon S, Brown F, Shaw D. Evidence for peritonitis treatment and prophylaxis. CARI guidelines. Update September 15, 2003. Available at: http://www.kidney.org.au/cari/drafts/peritonitis.html. Accessed: May 2004.
76. Keane WF, Baile GR, Boeschoten E, et al. International Society for Peritoneal Dialysis, adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 Update. Perit Dial Int 2000; 20: 396-411.
77. Gokal R, Alexander S, Ash S, et al. Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 Update. (Official report from the International Society for Peritoneal Dialysis). Perit Dial Int 1998; 18: 11-33.
78. Hospital Infection Control Practices Advisory Commitee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995; 16: 105-13.
79. Ansell D, Feest T. UK Renal Registry Report 2002. Bristol, UK: Renal Registry; 1998.
80. Gokal R, Alexander S, Ash S, Chen TW, Danielson A, Holmes C, Joffe P, Moncrief J, Nichols K, Piraino B, Prowant B, Slingeneyer A, Stegmayr B, Twardowski Z, Vas S. Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 update (Official report from the International Society for Peritoneal Dialysis). Perit Dial Int 1998; 18: 11-33.